What is Vital Oxide?
Vital Oxide is at the forefront of developing and distributing EPA-registered, hospital-grade disinfectants. Their proprietary antimicrobial solution is engineered to eliminate 99.999% of viruses and bacteria, making it a critical asset for healthcare, education, agriculture, and hospitality industries. The company serves both residential and commercial markets, offering a non-corrosive, non-irritating formula suitable for food contact surfaces without the need for rinsing. Vital Oxide's product line addresses essential needs such as mold remediation, odor elimination, and comprehensive sanitation, positioning them as a key player in public health and safety solutions.
How much funding has Vital Oxide raised?
Vital Oxide has raised a total of $5.2M across 2 funding rounds:
Corporate Investment
$5M
Debt
$150K
Corporate Investment (2019): $5M with participation from Avnet
Debt (2020): $150K led by PPP
Key Investors in Vital Oxide
Avnet
Avnet, a global electronic components distributor with extensive design and supply chain expertise, has provided corporate investment to Vital Oxide. Their involvement suggests a strategic alignment with technology-driven solutions in the health and safety sector.
PPP
Public-Private Partnership
What's next for Vital Oxide?
The recent major strategic investment in Vital Oxide suggests a strong validation of its business model and product efficacy, particularly in the current global health landscape. This capital infusion is likely to fuel further research and development, enhance production capabilities, and expand market reach into new territories and applications. As Vital Oxide continues to scale its operations, it is poised to solidify its position as a leading provider of advanced disinfecting and sanitizing technologies, potentially exploring new product formulations or strategic partnerships to broaden its impact.
See full Vital Oxide company page
